Logo image of TRX

TRX GOLD CORP (TRX) Stock Fundamental Analysis

NYSEARCA:TRX - NYSE Arca - CA87283P1099 - Common Stock - Currency: USD

0.3196  -0.01 (-3.15%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TRX. TRX was compared to 150 industry peers in the Metals & Mining industry. There are concerns on the financial health of TRX while its profitability can be described as average. TRX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

TRX had negative earnings in the past year.
TRX had a positive operating cash flow in the past year.
In multiple years TRX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: TRX reported negative operating cash flow in multiple years.
TRX Yearly Net Income VS EBIT VS OCF VS FCFTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.41%, TRX is in the better half of the industry, outperforming 74.13% of the companies in the same industry.
TRX has a Return On Equity of 8.08%. This is in the better half of the industry: TRX outperforms 73.43% of its industry peers.
TRX has a better Return On Invested Capital (12.43%) than 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TRX is in line with the industry average of 8.82%.
The last Return On Invested Capital (12.43%) for TRX is above the 3 year average (8.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.41%
ROE 8.08%
ROIC 12.43%
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
TRX Yearly ROA, ROE, ROICTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

TRX has a Profit Margin of 10.23%. This is amongst the best in the industry. TRX outperforms 81.12% of its industry peers.
With an excellent Operating Margin value of 29.23%, TRX belongs to the best of the industry, outperforming 88.11% of the companies in the same industry.
TRX has a better Gross Margin (43.01%) than 82.52% of its industry peers.
Industry RankSector Rank
OM 29.23%
PM (TTM) 10.23%
GM 43.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRX Yearly Profit, Operating, Gross MarginsTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TRX is still creating some value.
The number of shares outstanding for TRX has been increased compared to 1 year ago.
TRX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TRX is higher compared to a year ago.
TRX Yearly Shares OutstandingTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TRX Yearly Total Debt VS Total AssetsTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that TRX is in the distress zone and has some risk of bankruptcy.
TRX's Altman-Z score of 0.37 is on the low side compared to the rest of the industry. TRX is outperformed by 81.12% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that TRX is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.03, TRX is doing good in the industry, outperforming 69.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACC1.33
WACC9.35%
TRX Yearly LT Debt VS Equity VS FCFTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

TRX has a Current Ratio of 0.83. This is a bad value and indicates that TRX is not financially healthy enough and could expect problems in meeting its short term obligations.
TRX's Current ratio of 0.83 is on the low side compared to the rest of the industry. TRX is outperformed by 90.21% of its industry peers.
A Quick Ratio of 0.51 indicates that TRX may have some problems paying its short term obligations.
TRX has a worse Quick ratio (0.51) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.51
TRX Yearly Current Assets VS Current LiabilitesTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.51% over the past year.
TRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.49%.
EPS 1Y (TTM)57.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2485.71%
Revenue 1Y (TTM)16.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 32.50% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year44.57%
Revenue Next 2Y32.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
TRX Yearly Revenue VS EstimatesTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
TRX Yearly EPS VS EstimatesTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.02 -0.02 0.04 0.06

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Forward Earnings ratio is 4.87, which indicates a rather cheap valuation of TRX.
Based on the Price/Forward Earnings ratio, TRX is valued cheaper than 97.90% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.06. TRX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.87
TRX Price Earnings VS Forward Price EarningsTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TRX is valued cheaply inside the industry as 82.52% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.64
TRX Per share dataTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

The decent profitability rating of TRX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRX GOLD CORP

NYSEARCA:TRX (2/21/2025, 11:29:00 AM)

0.3196

-0.01 (-3.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)01-14 2025-01-14/amc
Earnings (Next)04-10 2025-04-10/amc
Inst Owners1.25%
Inst Owner Change43.06%
Ins Owners1.14%
Ins Owner ChangeN/A
Market Cap90.08M
Analysts80
Price Target1.22 (281.73%)
Short Float %0.1%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.25%
Min EPS beat(2)-100%
Max EPS beat(2)-50.49%
EPS beat(4)0
Avg EPS beat(4)-112.38%
Min EPS beat(4)-199.01%
Max EPS beat(4)-50.49%
EPS beat(8)0
Avg EPS beat(8)-106.19%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.33%
Min Revenue beat(2)-22.73%
Max Revenue beat(2)-7.94%
Revenue beat(4)0
Avg Revenue beat(4)-20.09%
Min Revenue beat(4)-26.59%
Max Revenue beat(4)-7.94%
Revenue beat(8)0
Avg Revenue beat(8)-18.51%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10%
PT rev (3m)-13.25%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-21.05%
EPS NY rev (3m)-21.05%
Revenue NQ rev (1m)-31.23%
Revenue NQ rev (3m)-31.23%
Revenue NY rev (1m)4.22%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.87
P/S 2.03
P/FCF N/A
P/OCF 7.17
P/B 1.61
P/tB 1.61
EV/EBITDA 5.64
EPS(TTM)0
EYN/A
EPS(NY)0.07
Fwd EY20.54%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.04
OCFY13.94%
SpS0.16
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.41%
ROE 8.08%
ROCE 15.74%
ROIC 12.43%
ROICexc 13.55%
ROICexgc 13.55%
OM 29.23%
PM (TTM) 10.23%
GM 43.01%
FCFM N/A
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
ROICexc(3y)9.9%
ROICexc(5y)N/A
ROICexgc(3y)10.18%
ROICexgc(5y)N/A
ROCE(3y)10.33%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.12
Cap/Depr 502.61%
Cap/Sales 30.46%
Interest Coverage 250
Cash Conversion 80.36%
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.51
Altman-Z 0.37
F-Score4
WACC9.35%
ROIC/WACC1.33
Cap/Depr(3y)4701.66%
Cap/Depr(5y)4096.58%
Cap/Sales(3y)58.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2485.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.22%
Revenue Next Year44.57%
Revenue Next 2Y32.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1622.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y78.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.1%
OCF growth 3YN/A
OCF growth 5YN/A